BioLargo’s Aqueous Electrostatic Concentrator generates a fraction of the waste product of competing technologies
PFAS are an expansive group of man-made chemicals used for
decades in the manufacture of countless goods, including non-stick cookware, fast-food
containers, and firefighting foam. PFAS have been linked to numerous health
problems including cancer and developmental issues, and are challenging to
remove from water using traditional treatment techniques.
While traditional water filtration treatment technologies such
as granular activated carbon, ion exchange, and membrane filtration may meet these
new EPA standards on some PFAS species, they can fall short of achieving
sufficient removal rates for short-chain PFAS molecules (such as the
now-EPA-regulated GenX and PFHXS). They also have the significant downside of
producing large volumes of PFAS-laden solid waste, which requires additional disposal
costs and creates potential regulatory liability.
These new EPA regulations mark a shift in the evolving
market for PFAS treatment technologies. Previously driven by a patchwork of
state and local drinking water regulations, drinking water providers across the
country will have to comply with the new federal standards. The EPA estimates compliance
with the new rules will cost approximately $1.5 billion annually; spending in other
industry segments is not included in that estimate (e.g., treatment of
groundwater, wastewater, industrial wastewater, or landfill leachate).
“These long-awaited drinking water regulations are a big win
for our technology,” commented Tonya Chandler, President of BioLargo Equipment
Solutions & Technologies, BioLargo’s water equipment subsidiary. “Our AEC
has an edge over the competition, as it can meet these new standards for all
PFAS contaminants and generates far less PFAS-laden waste requiring disposal.”
In addition to these new standards, in February 2024 the EPA
proposed changes to the Resource Conservation and Recovery Act regulations by
adding nine PFAS chemical compounds to its list of hazardous constituents in
Title 40 of the Code of Federal Regulations Part 261 Appendix VIII.
“If these RCRA rules are finalized, costs associated with
handling and disposing of PFAS-laden solid waste will likely become more
expensive and difficult, giving our product a significant cost advantage over
the competition,” said Ms. Chandler.
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences
innovator and engineering services solution provider. Our core products address
PFAS contamination, achieve advanced water and wastewater treatment, control
odor and VOCs, improve air quality, enable energy-efficiency and safe on-site
energy storage, and control infections and infectious disease. Our approach is
to invent or acquire novel technologies, develop them into product offerings,
and extend their commercial reach through licensing and channel partnerships to
maximize their impact. See our website at www.BioLargo.com.
About BioLargo Equipment Solutions & Technologies
BioLargo Equipment Solutions & Technologies, Inc. sells
and distributes sustainable, best-in-class water treatment systems that solve
some of the toughest challenges in the modern water industry. From PFAS capture
and destruction to water reuse technologies, every system delivers on a promise
of uncompromising technical performance, sustainable energy usage and waste
generation metrics, and clear ROI for operations that use them. Its website is www.biolargoequipment.com. BioLargo
Equipment Solutions & Technologies, Inc. is a wholly owned subsidiary of
BioLargo, Inc., a cleantech innovator and environmental engineering solutions
provider dedicated to make life better through technological innovation.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include without limitation those about
BioLargo’s (the “Company”) expectations regarding anticipated revenue; and
plans for future operations. These statements involve risks and uncertainties,
and actual results may differ materially from any future results expressed or
implied by the forward-looking statements. Risks and uncertainties include without
limitation: the effect of regional economic conditions on the Company’s
business, including effects on purchasing decisions by consumers and
businesses; the ability of the Company to compete in markets that are highly
competitive and subject to rapid technological change; the ability of the
Company to manage frequent introductions and transitions of products and
services, including delivering to the marketplace, and stimulating customer
demand for, new products, services, and technological innovations on a timely
basis; the dependency of the Company on the performance of distributors of the
Company’s products. More information on these risks and other potential factors
that could affect the Company’s business and financial results is included in
the Company’s filings with the SEC, including in the “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results of
Operations” sections of the Company’s most recently filed periodic reports on
Form 10-K and Form 10-Q and subsequent filings. The Company assumes no
obligation to update any forward-looking statements or information, which speak
as of their respective dates.
